Core Viewpoint - Kintor Pharmaceutical Co., Ltd. (06990) has entered into a structured deposit agreement with Bank of China, committing to invest RMB 440 million in structured deposits, which are expected to yield higher returns than traditional bank deposits [1] Summary by Relevant Sections - **Investment Details** - The company has agreed to subscribe to structured deposits amounting to RMB 440 million with Bank of China [1] - The structured deposits are characterized as capital-protected financial products with floating returns [1] - **Expected Benefits** - The anticipated return rate from these structured deposits is expected to exceed that of general commercial bank deposits [1] - This investment is aimed at improving the efficiency of the company's idle funds [1] - **Management's Perspective** - The board believes that the terms of the structured deposit agreement are fair and reasonable [1] - The investment aligns with the overall interests of the company's shareholders [1]

格隆汇9月29日丨科伦博泰生物-B(06990.HK)公告，2025年9月29日，公司订立中国银行结构性存款协 议，据此，公司同意认购本金额为人民币4.4亿元的中国银行结构性存款。 ...

公告称，考虑到具有浮动回报的保本理财产品的性质，预期回报率，及理财产品的中短期性质，使用集 团闲置自有资金认购中国银行结构性存款将获得高于一般商业银行存款的回报，并且有利于提高集团闲 置资金的使用效率。董事认为中国银行结构性存款的条款属公平合理，并符合公司股东的整体利益。 科伦博泰生物-B(06990)发布公告，2025年9月29日，公司订立中国银行结构性存款协议，据此，公司同 意认购本金额为人民币4.4亿元的中国银行结构性存款。 ...